---
title: "Barborka - Drake C — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9c07e089-e48b-5952-b29a-1004733503f3
json: https://whiteintel.dev/api/public/dossier/9c07e089-e48b-5952-b29a-1004733503f3
identifier: icij:icijol-80033273
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Barborka - Drake C

**Type:** Organization  
**Jurisdiction:** US  
**Identifier:** `icij:icijol-80033273`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9c07e089-e48b-5952-b29a-1004733503f3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9c07e089-e48b-5952-b29a-1004733503f3  

## Ownership & control

### Holdings / subsidiaries

- **Allergan Pharmaceuticals Ireland** (director of) — https://whiteintel.dev/entity/7bafda37-190e-55be-bd32-1b5891d3eb67

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/80033273

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Barborka - Drake C**. Human view: https://whiteintel.dev/entity/9c07e089-e48b-5952-b29a-1004733503f3 · Structured JSON: https://whiteintel.dev/api/public/dossier/9c07e089-e48b-5952-b29a-1004733503f3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._